Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4169569
Max Phase: Preclinical
Molecular Formula: C30H35N7O3S4
Molecular Weight: 669.92
Molecule Type: Small molecule
Associated Items:
ID: ALA4169569
Max Phase: Preclinical
Molecular Formula: C30H35N7O3S4
Molecular Weight: 669.92
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(=O)[nH]c(CSC(=S)N(CCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)Cc3ccc(C#N)cc3)nc2s1
Standard InChI: InChI=1S/C30H35N7O3S4/c1-18-13-21-27(39)34-24(35-28(21)44-18)17-43-30(41)37(15-20-9-7-19(14-31)8-10-20)12-4-11-32-25(38)6-3-2-5-23-26-22(16-42-23)33-29(40)36-26/h7-10,13,22-23,26H,2-6,11-12,15-17H2,1H3,(H,32,38)(H2,33,36,40)(H,34,35,39)/t22-,23-,26-/m0/s1
Standard InChI Key: JVMLXPPSZQKHFT-FXSPECFOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 669.92 | Molecular Weight (Monoisotopic): 669.1684 | AlogP: 4.42 | #Rotatable Bonds: 13 |
Polar Surface Area: 143.01 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.39 | CX Basic pKa: 2.83 | CX LogP: 3.64 | CX LogD: 3.64 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.12 | Np Likeness Score: -1.64 |
1. Yang CR, Peng B, Cao SL, Ren TT, Jiang W, Wang FC, Li YS, Wang G, Li Z, Xu S, Liao J, Wang H, Li J, Xu X.. (2018) Synthesis, cytotoxic evaluation and target identification of thieno[2,3-d]pyrimidine derivatives with a dithiocarbamate side chain at C2 position., 154 [PMID:29843103] [10.1016/j.ejmech.2018.05.028] |
Source(1):